Estimated Revenue: $1M to $10M
Funding Status: IPO
Headquarters: Boston, Massachusetts, United States
Total Funding: 224000000.0
Last Funding Date: 2022-12-13
Investors Number: 11.0
Founded Date: 2012-01-01
Technology: Biotechnology, Health Care, Medical Device
Industry: End-to-End Drug Development
Last Funding Type: Post-IPO Equity
Employee Number: 101-250